Neuberger Berman Group’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-58,000
Closed -$1.07M 1861
2017
Q3
$1.07M Buy
58,000
+35,000
+152% +$606K ﹤0.01% 1141
2017
Q2
$381K Buy
+23,000
New +$320K ﹤0.01% 1361

Other funds holding ENTL

Neuberger Berman Group's ENTL Position: Q4 2017 in Review

Neuberger Berman Group sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q4 2017, closing a stake of 58,000 shares — an estimated $1.07M sold.

Neuberger Berman Group first reported a position in ENTL in Q2 2017 and held it in 2 quarters. The position peaked at $1.07M in Q3 2017. 83 funds tracked by Wall St. Rank hold ENTL as of Q4 2017.

  • Neuberger Berman Group reported no remaining Entellus Medical, Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
  • Neuberger Berman Group sold 58,000 Entellus Medical, Inc. Common Stock shares in Q4 2017, an estimated $1.07M.
  • Neuberger Berman Group first reported a position in Entellus Medical, Inc. Common Stock in Q2 2017 and held it in 2 quarters.
  • Neuberger Berman Group's Entellus Medical, Inc. Common Stock position peaked at $1.07M in Q3 2017.
  • 83 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q4 2017.

Based on Neuberger Berman Group's 13F filing for Q4 2017, filed 14 Feb 2018.